Third Wave Technologies Inc. (TWTI) Enters Strategic Partnership with DCL Medical Laboratories; Receives Clearance from FDA for Cystic Fibrosis Screening Test
Third Wave Technologies Inc. (TWTI), headquartered in Madison, Wisconsin, develops and markets molecular diagnostic reagents for a variety of DNA and RNA analysis applications to meet the needs of customers. The company offers a number of products based on its Invader® chemistry for clinical testing. Third Wave offers in-vitro diagnostic kits, and analyte-specific, general purpose, and research-use only reagents for nucleic acid analysis. The company received clearance from the US Food and Drug Administration for its InPlex™ CF Molecular Test. The test simultaneously detects and identifies cystic fibrosis mutations in patient DNA samples. Cystic fibrosis is a fatal disease that…